EGM
IMGN

Engineers Gate Manager’s Immunogen Inc IMGN Stock Holding History

Engineers Gate Manager’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,651
Closed -$2.6M – 2402
2023
Q4 		$2.6M Buy
+87,651
New +$1.75M 0.07% 371
2022
Q4 		– Sell
-20,526
Closed -$98K – 2117
2022
Q3 		$98K Buy
+20,526
New +$108K 0.01% 1454
2022
Q2 		– Sell
-87,600
Closed -$417K – 2337
2022
Q1 		$417K Buy
87,600
+29,400
+51% +$163K 0.02% 1169
2021
Q4 		$432K Buy
58,200
+33,500
+136% +$208K 0.02% 1162
2021
Q3 		$140K Sell
24,700
-22,483
-48% -$130K 0.01% 1494
2021
Q2 		$311K Sell
47,183
-7,417
-14% -$51.7K 0.02% 1109
2021
Q1 		$442K Buy
54,600
+4,700
+9% +$38.4K 0.02% 1067
2020
Q4 		$322K Buy
+49,900
New +$291K 0.01% 1255
2020
Q3 		– Sell
-11,900
Closed -$55K – 2051
2020
Q2 		$55K Buy
+11,900
New +$50.6K ﹤0.01% 1636
2018
Q1 		– Sell
-23,200
Closed -$149K – 1019
2017
Q4 		$149K Buy
+23,200
New +$143K 0.01% 691

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Engineers Gate Manager's IMGN Position: Q1 2024 in Review

Engineers Gate Manager sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 87,651 shares — an estimated $2.6M sold.

Engineers Gate Manager first reported a position in IMGN in Q4 2017 and held it in 10 quarters. The position peaked at $2.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Engineers Gate Manager reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 87,651 Immunogen Inc shares in Q1 2024, an estimated $2.6M.
  • Engineers Gate Manager first reported a position in Immunogen Inc in Q4 2017 and held it in 10 quarters.
  • Engineers Gate Manager's Immunogen Inc position peaked at $2.6M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.